-
Posted: September 5th, 2010, 2:00am CDT
The decision regarding treatment following breast-conserving surgery for patients diagnosed with ductal carcinoma in-situ (DCIS) has long been an area of discussion and confusion for patients and physicians alike. While the mortality rates for DCIS remain low, the risk of local recurrence in the breast is high. Standard treatments following surgery include radiation therapy and hormone treatment...
-
Posted: September 5th, 2010, 2:00am CDT
Recent studies have shown that acupuncture can help control a number of symptoms and side effects -- such as pain, fatigue, dry mouth, nausea, and vomiting -- associated with a variety of cancers and their treatments...
-
Posted: September 5th, 2010, 2:00am CDT
About one-third of women diagnosed with early-stage breast cancer will have their cancer travel, or metastasize, to other parts of the body, with the bone being the most common site of initial detectable spread...
-
Posted: September 4th, 2010, 2:00am CDT
New research uncovers a case of mistaken identity that may have a significant impact on future breast cancer prevention and treatment strategies. The study, published by Cell Press in the September 3rd issue of the journal Cell Stem Cell, suggests that despite their "stem cell-like" characteristics, most aggressive breast tumors are not derived from normal mammary gland stem cells...
-
Posted: September 3rd, 2010, 10:00am CDT
Researchers have made a major breakthrough in finding out how aggressive cancers originate, raising hope of novel targeted therapies for future breast cancer patients, according to a study published in the peer-reviewed journal Cell Stem Cell...
-
Posted: September 2nd, 2010, 7:00am CDT
A study published in the Journal of the American Medical Association suggests that women with a gene mutation linked to breast and ovarian cancer face lower risks of developing such cancer after receiving mastectomies or having their ovaries removed, The Wall Street Journal reports...
-
Posted: September 2nd, 2010, 6:00am CDT
Using readily available computer programs, researchers have developed a system to identify genes that will be useful in the classification of breast cancer. The algorithm, described in BioMed Central's open access Journal of Experimental & Clinical Cancer Research will enable researchers to quickly generate valuable gene signatures without specialized software or extensive bioinformatics training...
-
Posted: September 2nd, 2010, 5:00am CDT
Specific prevention and education strategies are needed to address breast cancer in Mexican-origin women in this country, according to a study at The University of Texas MD Anderson Cancer Center, which was published online in the journal Cancer...
-
Posted: September 2nd, 2010, 5:00am CDT
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the U.S. Food and Drug Administration (FDA) issued a Refuse to File letter for accelerated approval for the company's trastuzumab-DM1 (T-DM1) Biologics License Application (BLA). As planned Roche will continue with its ongoing Phase III EMILIA registration study...
-
Posted: September 2nd, 2010, 3:00am CDT
When breast cancer surgeons regularly confer with plastic surgeons prior to surgery, their patients are more likely to have reconstruction, according to a new study led by researchers at the University of Michigan Comprehensive Cancer Center. Where a woman goes for breast cancer treatment can vary widely - ranging from small private practices to large hospital settings...
-
Posted: September 2nd, 2010, 3:00am CDT
The ASCO Post captured initial reactions to the Oncologic Drugs Advisory Committee (ODAC) recommendation that the breast cancer indication for bevacizumab (Avastin) be revoked in interviews with ODAC voting members, breast cancer specialists, oncologists in private practice, third-party payers, and a patient advocate....
-
Posted: September 1st, 2010, 8:00am CDT
Eisai Inc. announced today that it has received notification from the U.S...
-
Posted: September 1st, 2010, 7:00am CDT
Girls eating a high-fat diet during puberty, even those who do not become overweight or obese, may be at a greater risk of developing breast cancer later in life, according to Michigan State University researchers. The implications - that a high-fat diet may have detrimental effects independent of its effect to cause obesity - could drive new cancer prevention efforts...
-
Posted: September 1st, 2010, 5:00am CDT
A 51-year-old breast cancer patient from Switzerland has become the first person in the world to be treated using Gated RapidArc®, which makes it possible to monitor patient breathing and compensate for tumor motion while quickly delivering radiotherapy during a continuous rotation around the patient...
-
Posted: September 1st, 2010, 3:00am CDT
Women with the inherited mutations of the BRCA1 or BRCA2 genes who had preventive (prophylactic) breast removal (mastectomy) or the removal of the fallopian tubes and ovaries (salpingo-oophorectomy) were found to have a significantly lower risk of developing ovarian and breast cancers, says a study published in JAMA (Journal of the American Medical Association), September 1st issue...
-
Posted: August 31st, 2010, 6:00am CDT
ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops antibody-based targeted anticancer products, announced that Genentech, a member of the Roche Group, announced its receipt of a Refuse to File (RTF) letter from the US Food and Drug Administration (FDA) for the accelerated approval of the Biologic License Application (BLA) for trastuzumab-DM1, or T-DM1, submitted in July 2010...
-
Posted: August 31st, 2010, 5:00am CDT
For the first time, researchers at Fred Hutchinson Cancer Research Center have identified and isolated adult mammary stem cells in mice. Long-term implications of this research may include the use of such cells to regenerate breast tissue, provide a better understanding of the role of adult stem cells in breast cancer development, and develop potential new targets for anti-cancer drugs...
-
Posted: August 30th, 2010, 4:00am CDT
AARP Bulletin: "Two years after undergoing a double mastectomy and chemotherapy so severe she was hospitalized in intensive care for several weeks, breast cancer survivor Denise Hicks should be following what her doctors call 'the plan,'" which includes additional medications and treatments. But she can't. "Hicks has health insurance but already reached her coverage limits...
-
Posted: August 29th, 2010, 2:00am CDT
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced the U.S. Food and Drug Administration (FDA) issued a Refuse to File letter for accelerated approval for the company's trastuzumab-DM1 (T-DM1) Biologics License Application (BLA). As planned, Genentech will continue with its ongoing Phase III registrational T-DM1 trial, EMILIA...
-
Posted: August 28th, 2010, 10:00am CDT
A new test has been developed which can predict whether a breast cancer patient will respond to chemotherapy within 24-hours of starting treatment, thus sparing her unnecessary treatment and side effects, according to a study published in the medical journal Clinical Cancer Research...
-
Posted: August 28th, 2010, 4:00am CDT
Preferred Imaging Centers has installed the Naviscan PEM scanner into its newest facility in Plano, TX, adding a dedicated breast imaging modality to its array of diagnostic tools. PEM (Positron Emission Mammography) scanners are high-resolution breast PET systems that show the location as well as the metabolic phase of a lesion...
-
Posted: August 27th, 2010, 9:00am CDT
The Food and Drug Administration (FDA) has issued a Refuse to File letter for accelerated approval of Roche's trastuzumab-DM1 (T-DM1) Biologics License Application, which was submitted in July 2010. Roche had requested accelerated approval for T-DM1 based on the results of a single-arm Phase II study. In that study one third of advanced HER2 positive breast cancer tumors shrank...
-
Posted: August 27th, 2010, 2:00am CDT
Some nuclear-based breast imaging exams may increase a woman's risk of developing radiation-induced cancer, according to a special report appearing online and in the October issue of Radiology. However, the radiation dose and risk from mammography are very low...
-
Posted: August 26th, 2010, 6:00am CDT
Two articles published in the Aug. 24 issue of the journal Radiology suggest that doctors should more carefully consider the risks of radiation exposure when employing advanced diagnostic techniques to screen for breast cancer, the New York Times reports...
-
Posted: August 26th, 2010, 6:00am CDT
USA Today recently published an editorial and an opinion piece regarding the recent controversy surrounding the cancer drug Avastin. An FDA advisory panel in July voted 12-1 to recommend that the agency revoke Avastin's approval to treat advanced breast cancer after two clinical trials showed it did not prolong life. FDA is expected to make its final decision by Sept. 17, USA Today reports...
-
Posted: August 25th, 2010, 1:00pm CDT
Scientists have discovered that when nicotine binds to nAchRs (nicotinic acetylcholine receptors), it may not only promote addiction, but breast cancer as well. We know that non-nicotine components of smoking are carcinogens, however, very little is known about how nicotine acts on cells to encourage cancer growth, the scientists explain...
-
Posted: August 25th, 2010, 6:00am CDT
Breast cancer survivor Sheryl Crow and the Pink Lotus Breast Center announced the grand opening of the Sheryl Crow Imaging Center, a state of the art breast imaging center featuring the latest advancements in digital screening and diagnostic imaging technologies...
-
Posted: August 25th, 2010, 5:00am CDT
In a recent study presented at the American Association of Physicists in Medicine (AAPM) 52nd Annual Meeting, researchers at the University of Washington showed that 18FDG dose for Positron Emission Mammography (PEM) may be reduced by as much as 70% without altering image quality...
-
Posted: August 25th, 2010, 3:00am CDT
A desire to understand how breast cancer starts has seen Walter and Eliza Hall Institute researcher Dr Marie-Liesse Asselin-Labat win one of three 2010 L'Oreal Australia For Women in Science Fellowships...
-
Posted: August 25th, 2010, 2:00am CDT
A key step in understanding the origins of familial breast cancer has been made by two teams of scientists at the University of California, Davis. The researchers have purified, for the first time, the protein produced by the breast cancer susceptibility gene BRCA2 and used it to study the oncogene's role in DNA repair...